Showing results (11-20 of 137) with videos related to
Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1990
Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangementsD Stoppa-Lyonnet, P E Carter, T Meo, et al.Pathologie-Biologie|August 10, 2010
[Cancer genetic predisposition: current events and perspectives in 2010]D Stoppa-Lyonnet, M H Stern, N Soufir, et al.Bulletin Du Cancer|September 12, 2009
[Estimation of individual breast cancer risk: relevance and limits of risk estimation models]A De Pauw, D Stoppa-Lyonnet, N Andrieu, et al.British Journal of Cancer|February 19, 2004
Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriersM Fernet, N Moullan, A Lauge, et al.Cancer Research|March 15, 1996
Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivityE Duchaud, A Ridet, D Stoppa-Lyonnet, et al.The New England Journal of Medicine|July 2, 1987
Altered C1 inhibitor genes in type I hereditary angioedemaD Stoppa-Lyonnet, M Tosi, J Laurent, et al.Annales De Dermatologie Et De Venereologie|January 1, 1987
[HLA markers and complotypes: risk factors in systemic lupus erythematosus?]A Gougerot, D Stoppa-Lyonnet, J C Poirier, et al.Pathologie-Biologie|June 1, 1986
[Familial studies of systemic lupus erythematosus. HLA markers and complotypes]D Stoppa-Lyonnet, A Gougerot, J C Poirier, et al.Gynecologic Oncology Reports|September 20, 2021
Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variantsM-C Villy, J Masliah-Planchon, S Melaabi, et al.The Surgical Clinics of North America|November 26, 1999
Genetic testing for breast cancer predispositionM Gauthier-Villars, S Gad, V Caux, et al.Pageof 14